Female Pattern Hair Loss: Signs, Stages, Causes and Treatment
How female pattern hair loss starts, how the Ludwig and Sinclair scales grade it, which tests rule out other causes, and what minoxidil, spironolactone and a transplant can and cannot do.
37sources
37in PubMed
14min read
Written by Nazmi Güldeş, Certified Trichologist · Medically reviewed by Dr. Teuku Adifitrian, Sp.BP-RE (Dr. Tompi), Plastic, Reconstructive and Aesthetic Surgeon · Last reviewed 30 October 2026
Reading level
Female pattern hair loss is gradual thinning on the top of the scalp: the central part widens while the front hairline usually stays where it was.[1] It is the most common type of hair loss in women, and it becomes more frequent with age.[2][3]
It can usually be slowed, and grading it early leaves more hair to protect.[4] Here are the signs, the stages, the tests and the treatments, with the evidence for each.
1Quick answerThe short answer, in a few sentences
What Is Female Pattern Hair Loss?
Female pattern hair loss (FPHL) is the female form of androgenetic alopeciaGlossaryAndrogenetic alopecia, or pattern baldness, is the pattern hair loss behind most male and female thinning. It is primarily driven by genetic predisposition and sensitivity to androgen hormones. Open in the glossary →. Follicles on the top of the scalp shrink with each hair cycle and grow finer, shorter hairs, so the central part widens while the front hairline is usually kept.[2][1] Topical minoxidil is the first-line treatment.[1]
An expert task force of the Androgen Excess and PCOS Society recommends the name female pattern hair loss over androgenetic alopecia.[1]
On its own, FPHL with normal androgen levels should not be read as a sign of a hormone disorder.[1]
2Complete guideFrom the first signs to treatment and surgery
Signs, Stages and Causes
What Early Female Pattern Hair Loss Looks Like
The first change is often volume rather than bare skin, and diffuse thinning can come years before any bald area.[5] Doctors describe two typical layouts: a part that widens outwards from the middle, and a "Christmas tree" pattern that is heavier towards the front.[1]
More scalp showing on the crownGlossaryThe crown, also called the vertex, is the highest point at the back of the head, where hair grows out in a spiral. Crown and vertex are two names for the same area. Open in the glossary → and upper sides of the head, with the front hairline spared[6]
Heavier shedding: 70% of women with FPHL shed at an excessive level[5]
Receding temples are not a male-only trait: in one Australian town survey, 64.4% of women had some hair loss at both temples.[7]
Female Pattern Hair Loss Stages: Ludwig and Sinclair Scales
The Ludwig scale, from 1977, has three grades of thinning on top with the front hairline intact, from grade I (minimal) to grade III (severe).[4][8] The Sinclair scale has five grades, based on how the central part looks from above.[5][9] Men are graded on the Norwood scale instead.
The Sinclair scale, stages 1 to 5. Photos: Sinclair R, Torkamani N, Jones L, CC BY 4.0, via F1000Research.
The 2016 FPHL Severity Index combines shedding, midline density and trichoscopy so that doctors can pick up disease earlier than Ludwig I allows.[4]
What Causes It: Genes, Hormones and Age
Hair density in women behaves like a multifactorial trait, shaped by many factors rather than one gene.[3] The gene variants behind male balding do not explain the female form, and the genetics of FPHL are still uncertain.[12]
Androgens push follicles to shrink by shortening the growth phase, while oestrogens may protect them.[13] Yet FPHL also occurs in women whose androgen levels are normal.[14] For the hormone itself, read our page on DHT and hair loss.
In a survey of 26,226 Taiwanese women aged 30 and over, FPHL was linked with high fasting glucose, fewer births, use of the contraceptive pill and more than 16 hours of sun a week.[15] These are links, not proven causes. If you recently started or stopped the pill, see birth control and hair loss.
Female Pattern Hair Loss in Your 20s
It can start young. First signs of androgenetic alopecia usually appear in the teenage years, and the European S3 guideline puts the share of women affected at up to 42%.[16]
Frequency rises with age. In one dermatology clinic sample, 6% of women under 50 had FPHL, against 38% of women aged 70 and over.[3] Estimates differ between populations: 11.8% of Taiwanese women aged 30 and over had it.[15]
Female Pattern Hair Loss After Menopause and HRT
Hormone shifts can begin up to 10 years before periods stop. Falling oestrogen and a relative rise in androgens can lower hair density, thin each hair and change its texture, and FPHL is seen more often after menopause.[17]
The evidence for HRT as a hair treatment is thin. In a pilot of 11 postmenopausal women with FPHL, six months of estradiol improved the frontal hairline score, but the study had no control group.[18]
How Female Pattern Hair Loss Is Diagnosed
The diagnosis is mainly clinical: a doctor looks at the pattern, your history and the scalp up close.[1]
Blood Tests: PCOS, Iron and Thyroid
The PCOS Society task force says every woman with FPHL should be assessed for possible androgen excess.[1] Polycystic ovary syndrome (PCOS) is the most common hormonal disorder in women of reproductive age, and FPHL is more common in women who have it.[14]
The same task force calls tests for vitamin D, iron, zinc, thyroid hormones and prolactin optional but recommended.[1] Thyroid problems cause their own kind of shedding; our guide to thyroid hair loss lists the tests to ask about.
Iron is where studies disagree. One study found lower average ferritin in 52 women with androgenetic alopecia than in 11 women without hair loss.[19] A larger study of 381 women with hair loss and 76 without found iron deficiency no more common in FPHL than in women without hair loss, and the effect of correcting it on hair is unknown.[20]
Trichoscopy and Scalp Biopsy
Trichoscopy is a magnified look at the scalp. In a study of 131 women, three main signs pointed to FPHL: thinner hairs at the front than at the back, more than 10% very thin hairs at the front, and more than four "yellow dots". Two of these, or one plus two minor signs, diagnosed it with 98% specificity.[21]
A biopsy is rarely needed. The study authors suggest keeping it for women at mid-scalp grades 1 and 2, where FPHL and chronic telogen effluvium overlap.[9]
Female Pattern Hair Loss vs Telogen Effluvium
Telogen effluviumGlossaryTelogen effluvium is sudden diffuse shedding that follows illness, childbirth or stress. Shedding usually starts two to three months after the trigger, and it is usually self-limiting once the trigger is removed. Open in the glossary → is diffuse shedding, usually set off by physical stress such as childbirth or sudden weight loss.[22]
Topical minoxidilGlossaryMinoxidil is an established medication for certain types of hair loss. It is a drug, not a hair oil, and the FDA-approved label says not to use it for sudden or patchy hair loss. Open in the glossary → is the only FDA-approved treatment for FPHL.[13] In the Cochrane review, women using it were about twice as likely as women on placebo to report moderate or marked regrowth: 157 of 593 against 77 of 555.[2]
Which strength? The PCOS Society task force recommends 5%,[1] Japan's guideline recommends 1% twice daily,[28] and the Cochrane review found no difference between 2% and 5%.[2]
A once-daily 5% foam grew about as much hair as a twice-daily 2% solution at 24 weeks (23.9 against 24.2 hairs per cm²), though the trial missed its formal non-inferiority target.[30] How to apply it is in our minoxidil entry.
Low-Dose Oral Minoxidil
Low-dose oral minoxidil is used off-label. A 2025 meta-analysis of four randomized trials with 279 patients found no difference in hair density between tablets and topical solution, but excess hair growth was about twice as common on tablets.[25]
In 1,404 patients, two thirds of them women, excess hair growth affected 15.1%, light-headedness 1.7%, and 1.7% stopped because of side effects.[26]
A 2026 consensus panel that included hair transplant surgeons suggests starting women on 0.625 to 1.25 mg a day, at most 2.5 mg, after checking weight and blood pressure.[31] Japan's 2017 guideline, by contrast, advised against oral minoxidil.[28]
Spironolactone and Other Antiandrogens
Antiandrogens are added when hair loss is severe or there are signs of androgen excess.[1] In an open study of 80 women taking spironolactoneGlossarySpironolactone is a prescription water tablet that dermatologists use off-label for women with female pattern hair loss, because it blocks the effect of androgen hormones on the hair follicle. Open in the glossary → or cyproterone acetate for at least a year, 44% had regrowth, 44% stayed the same and 12% kept losing hair.[10]
A 2023 meta-analysis put the improvement rate at 56.6%: 65.8% with combination treatment and 43.2% with spironolactone alone.[27] Dosing, blood tests and pregnancy rules are on our spironolactone page.
FinasterideGlossaryFinasteride blocks the enzyme that turns testosterone into DHT, the hormone that shrinks follicles in male pattern hair loss. It is a prescription medicine with possible side effects, so it should be started and followed by a doctor. Open in the glossary → 1 mg did no better than placebo in women,[2] and Japan's guideline lists oral finasteride as contraindicated for FPHL.[28] Higher doses are sometimes used: in a retrospective review of 112 women on 2.5 mg a day, 65.2% improved significantly, but there was no comparison group.[32] More in our finasteride entry.
Lasers, PRP and Camouflage
Low-level laserGlossaryRed light therapy, or low-level light therapy (LLLT), is a non-invasive option for pattern hair loss. Clinical studies suggest it may improve hair density, but research does not prove it is consistently more effective than minoxidil. Open in the glossary → combs gave mixed results: hair counts rose, yet women did not rate them better than sham devices.[2] In a crossover trial of 20 women, PRP raised hair counts less than minoxidil, although only PRP improved quality of life.[29]
Camouflage helps while treatment takes effect. Hairpieces and partial hairpieces can be useful,[8] and some women need cosmetic camouflage alongside medical treatment.[6]
Hair Transplant for Women: Who Is a Candidate?
A transplant moves follicles from the donor areaGlossaryThe donor area is the back and sides of the head, where follicles resist DHT. An extracted follicle does not grow back in that spot, so extractions are spread out, and the donor supply is the limit of every plan. Open in the glossary → at the back of the head to the thinning zone. Women usually present with diffuse thinning across the crown and temples, while men tend to have defined areas of recession.[33]
The donor area is the weak point. In 90 women with FPHL, more severe loss went with lower hair density and thinner hairs at the back of the scalp as well as the front.[34] When miniaturization covers the whole scalp, the back included, a transplant is often ruled out and treatment stays medical.[35]
Other reasons a transplant is the wrong answer include unstable hair loss, scarring alopecia and unrealistic expectations.[36] Women should be checked for underlying causes before surgery, and shock loss afterwards is common in women.[37]
For suitable women, surgery can work. One surgeon's series of 751 women treated with FUTGlossaryIn FUT, a thin strip of skin is removed from the back of the head, divided into grafts of 1 to 4 hairs, and the wound is closed with stitches. It leaves a line scar, while FUE leaves tiny dots. Open in the glossary → over 31 years reported few complications, but 18% came back for a second session about four years later because their FPHL progressed.[11] That is why medication continues around surgery: in the 2026 consensus, oral minoxidil can generally be taken from 1 to 3 days after a transplant and topical minoxidil from 7 to 14 days after.[31]
Frequently Asked Questions
Can female pattern hair loss be reversed?
Partly, and mostly early. In the current model, loss becomes irreversible once the deepest follicle in each group miniaturizes and loses its muscle attachment.[5]
Is female pattern hair loss genetic?
Partly. Hair density in women behaves like a multifactorial trait,[3] and the genes linked to male balding do not explain the female form.[12]
Which hormone causes female pattern hair loss?
No single hormone. Androgens promote follicle shrinkage and oestrogens may protect follicles,[13] but FPHL also occurs with normal androgen levels.[14]
Can stress cause female pattern hair loss?
Emotional and physical stress are recognised triggers of telogen effluvium, a shedding condition.[23] Early FPHL and chronic telogen effluvium can look alike, so have new shedding examined rather than guessing.[9]
Does female pattern hair loss ever stop?
It is progressive by nature.[6] Treatment aims to halt it: in the antiandrogen study, 88% of women saw no progression or saw improvement.[10]
Can you use minoxidil while pregnant?
The 2026 consensus advises avoiding minoxidil during pregnancy and breastfeeding.[31] For shedding after the birth, see our postpartum hair loss guide.
Medication, Surgery or Both: What Suits You?
Medical treatment suits most women with female pattern hair loss, and it works best early, while there is more hair to keep.[4] Expect to wait at least six months before you judge it.[24] Hair loss often weighs more heavily on women than on men, so get a clear diagnosis early.[13]
A transplant suits a smaller group: women whose loss is stable and patterned and whose donor area at the back is still dense.[36][34] If thinning covers the whole scalp, medication is the better route.[35]
Send us three photos for a free hair analysis and the medical team will tell you whether your pattern suits medication, surgery or both. You can also message us on WhatsApp.
About the Author
Written by: Nazmi Güldeş, Certified Trichologist. Nazmi Güldeş focuses on patient education around androgenetic alopecia, evaluating miniaturization through dermoscopy, and assessing candidates for medical treatments and hair transplants.
Editorial Policy & Trust
This entry was drafted with the help of AI writing tools and edited by our team, then medically reviewed by Dr. Teuku Adifitrian, Sp.BP-RE (Dr. Tompi) on 30 October 2026. AI is never used as a source: every study cited here was checked against PubMed on 30 October 2026, and each claim sits next to the study that supports it. Read how we work in our editorial policy.
3 questions
Test yourself
Check what you remember from this entry. Each answer links back to the section that explains it.
At Sinclair stages 3 to 5, how many women had female pattern hair loss on biopsy?
At stages 3 to 5, 97% of women had FPHL on triple biopsy; at stages 1 and 2 the figure was 60%. Read the section
Which treatment is the only FDA-approved option for female pattern hair loss?
Topical minoxidil is the only FDA-approved treatment; spironolactone and oral minoxidil are used off-label. Read the section
Why is a transplant often ruled out when thinning covers the whole scalp?
When miniaturization reaches the back of the scalp too, a transplant is often ruled out and treatment stays medical. Read the section
3Scientific evidenceStudy types, references and how to cite this entry
37sources
Evidence behind this entry: 37 publications indexed in PubMed (2001 to 2026): 16 reviews, 12 clinical studies, 3 guidelines, 3 systematic reviews, 2 randomized trials and 1 clinical trial. 12 sources have free full text.
Randomized trialpeople assigned to treatments by chance
Reviewsummarises many studies
Clinical studya study in people without random groups
Guideline or labela professional body, or the official drug label
Carmina E, Azziz R, Bergfeld W, et al. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. Journal of Clinical Endocrinology & Metabolism. 2019;104(7):2875-2891.GuidelinePubMedDOI
van Zuuren EJ, Fedorowicz Z, Schoones J. Interventions for female pattern hair loss. The Cochrane Database of Systematic Reviews. 2016;2016(5):CD007628.Systematic reviewPubMedDOIFree full text
Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. The British Journal of Dermatology. 2001;144(2):297-304.Clinical studyPubMedDOI
Harries M, Tosti A, Bergfeld W, et al. Towards a consensus on how to diagnose and quantify female pattern hair loss - The 'Female Pattern Hair Loss Severity Index (FPHL-SI)'. Journal of the European Academy of Dermatology and Venereology. 2016;30(4):667-676.ReviewPubMedDOI
Sinclair R, Torkamani N, Jones L. Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss. F1000Research. 2015;4(F1000 Faculty Rev):585.ReviewPubMedDOIFree full text
Bhat YJ, Saqib NU, Latif I, et al. Female Pattern Hair Loss-An Update. Indian Dermatology Online Journal. 2020;11(4):493-501.ReviewPubMedDOIFree full text
Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. The Journal of Investigative Dermatology Symposium Proceedings. 2005;10(3):184-189.Clinical studyPubMedDOI
Camacho-Martínez FM. Hair loss in women. Seminars in Cutaneous Medicine and Surgery. 2009;28(1):19-32.ReviewPubMedDOI
Sinclair R, Jolley D, Mallari R, et al. The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women. Journal of the American Academy of Dermatology. 2004;51(2):189-199.Clinical studyPubMedDOI
Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. The British Journal of Dermatology. 2005;152(3):466-473.Clinical trialPubMedDOI
Uebel CO, Piccinini PS, Spencer LSB, et al. Female Pattern Hair Loss: Why the Follicular Unit Transplantation Surgical Technique Remains a Good Option. Plastic and Reconstructive Surgery. 2021;147(4):839-849.Clinical studyPubMedDOI
Ho CY, Chen JY, Hsu WL, et al. Female Pattern Hair Loss: An Overview with Focus on the Genetics. Genes. 2023;14(7).ReviewPubMedDOIFree full text
Kearney CA, Brinks AL, Lawrence CN, et al. Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. American Journal of Clinical Dermatology. 2026;27(2):363-389.ReviewPubMedDOI
Jiang VS, Hawkins SD, McMichael A. Female pattern hair loss and polycystic ovarian syndrome: more than just hirsutism. Current Opinion in Endocrinology, Diabetes, and Obesity. 2022;29(6):535-540.ReviewPubMedDOI
Su LH, Chen LS, Chen HH. Factors associated with female pattern hair loss and its prevalence in Taiwanese women: a community-based survey. Journal of the American Academy of Dermatology. 2013;69(2):e69-77.Clinical studyPubMedDOI
Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. Journal of the European Academy of Dermatology and Venereology. 2018;32(1):11-22.GuidelinePubMedDOI
Gupta AK, Economopoulos V, Mann A, et al. Menopause and hair loss in women: Exploring the hormonal transition. Maturitas. 2025;198:108378.ReviewPubMedDOI
Endo Y, Obayashi Y, Murakoshi M, et al. Clinical and phototrichogrammatic evaluation of estradiol replacement therapy on hair growth in postmenopausal Japanese women with female pattern hair loss: a pilot study. International Journal of Women's Dermatology. 2023;9(4):e109.Clinical studyPubMedDOIFree full text
Kantor J, Kessler LJ, Brooks DG, et al. Decreased serum ferritin is associated with alopecia in women. The Journal of Investigative Dermatology. 2003;121(5):985-988.Clinical studyPubMedDOI
Olsen EA, Reed KB, Cacchio PB, et al. Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. Journal of the American Academy of Dermatology. 2010;63(6):991-999.Clinical studyPubMedDOI
Rakowska A, Slowinska M, Kowalska-Oledzka E, et al. Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria. International Journal of Trichology. 2009;1(2):123-130.Clinical studyPubMedDOIFree full text
Chien Yin GO, Siong-See JL, Wang ECE. Telogen Effluvium - a review of the science and current obstacles. Journal of Dermatological Science. 2021;101(3):156-163.ReviewPubMedDOI
Asghar F, Shamim N, Farooque U, et al. Telogen Effluvium: A Review of the Literature. Cureus. 2020;12(5):e8320.ReviewPubMedDOIFree full text
Iyengar L, Li J. Male and female pattern hair loss. Australian Prescriber. 2025;48(3):93-97.ReviewPubMedDOIFree full text
Sobral MVS, Moreira JLML, Rodrigues LK, et al. Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. International Journal of Dermatology. 2025;64(3):479-484.Systematic reviewPubMedDOI
Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. Journal of the American Academy of Dermatology. 2021;84(6):1644-1651.Clinical studyPubMedDOI
Aleissa M. The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis. Cureus. 2023;15(8):e43559.Systematic reviewPubMedDOIFree full text
Manabe M, Tsuboi R, Itami S, et al. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. The Journal of Dermatology. 2018;45(9):1031-1043.GuidelinePubMedDOI
Bruce AJ, Pincelli TP, Heckman MG, et al. A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women. Dermatologic Surgery. 2020;46(6):826-832.Randomized trialPubMedDOI
Blume-Peytavi U, Shapiro J, Messenger AG, et al. Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study. Journal of Drugs in Dermatology. 2016;15(7):883-889.Randomized trialPubMed
Gupta AK, Talukder M, Williams G, et al. Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern hair loss in hair transplant patients using a modified Delphi process. Expert Opinion on Pharmacotherapy. 2026;27(3):253-261.ReviewPubMedDOI
Won YY, Lew BL, Sim WY. Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss. Dermatologic Therapy. 2018;31(2):e12588.Clinical studyPubMedDOI
Queen D, Avram MR. Hair Transplantation in Women. Journal of Drugs in Dermatology. 2025;24(9):851-855.ReviewPubMedDOI
Michelle V, Shilpa K, Leelavathy B. A Clinico-Trichoscopic Analysis of Hair Density and Diameter Variability in Relation to Severity Grading of Female Pattern Hair Loss. International Journal of Trichology. 2022;14(5):162-171.Clinical studyPubMedDOIFree full text
Spindler A, Maas D, Zappi I, et al. Revisiting Diffuse Unpatterned Alopecia: Reappraisal of a Controversial Diagnosis. Skin Appendage Disorders. 2026.ReviewPubMedDOIFree full text
True RH. Is Every Patient of Hair Loss a Candidate for Hair Transplant?-Deciding Surgical Candidacy in Pattern Hair Loss. Indian Journal of Plastic Surgery. 2021;54(4):435-440.ReviewPubMedDOIFree full text
Lam SM. Hair Loss and Hair Restoration in Women. Facial Plastic Surgery Clinics of North America. 2020;28(2):205-223.ReviewPubMedDOI
Güldeş, N. (2026, October 30). Female pattern hair loss: Signs, stages, causes and treatment. Turkey Hair Center Hair Library. https://turkeyhaircenter.com/female-pattern-hair-loss/
@misc{guldes2026femalepatternhairloss,
author = {Güldeş, Nazmi},
title = {Female pattern hair loss: Signs, stages, causes and treatment},
howpublished = {Turkey Hair Center Hair Library},
year = {2026},
month = oct,
url = {https://turkeyhaircenter.com/female-pattern-hair-loss/},
note = {Last updated 30 October 2026}
}
TY - ELEC
AU - Güldeş, Nazmi
TI - Female pattern hair loss: Signs, stages, causes and treatment
T2 - Turkey Hair Center Hair Library
PY - 2026
DA - 2026/10/30
UR - https://turkeyhaircenter.com/female-pattern-hair-loss/
N1 - Last updated 30 October 2026
ER -
Send three photos: front, top and sides. You get a technique recommendation, a graft range and a straight answer about what is achievable, before anyone talks about price.
Your details are with the team
A patient coordinator will get back to you shortly. If you would like to send your photos now, WhatsApp is the fastest way to do it.
Turkey Hair Center is the hair-restoration brand of Healthy Way Tourism, an authorized international health-tourism intermediary. All medical procedures are performed by licensed medical professionals at authorized healthcare facilities in Turkiye, in accordance with the regulations of the Ministry of Health.